Stock Fundamentals

Company Information

Company Name
Skye Bioscience, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US83086J2006
CIK: 0001516551
CUSIP: 83086J101
Currency: USD
Full Time Employees: 2
Phone: 858 410 0266
Fiscal Year End: December
IPO Date: Apr 02, 2015
Description:

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Address:

11250 El Camino Real, San Diego, CA, United States, 92130

Directors & Officers

Name Title Year Born
Mr. Punit S. Dhillon B.A. President, CEO & Director 1980
Mr. Tu Diep M.Sc. Chief Operating Officer 1981
Mr. John P. Sharp CPA CFO and Principal Financial & Accounting Officer 1965
Dr. Christopher G. Twitty Ph.D. Chief Scientific Officer 1972
Dr. Puneet S. Arora FACE, M.D., M.S. Chief Medical Officer 1972

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 22, 2025 5Am Partners Vii, Llc N/A Sale 170.45K $3.42 $582.94K
Aug 22, 2025 Andrew J Schwab N/A Sale 170.45K $3.42 $582.94K
Aug 21, 2025 5Am Partners Vii, Llc N/A Sale 60.96K $3.57 $217.61K
Aug 21, 2025 Andrew J Schwab N/A Sale 60.96K $3.57 $217.61K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
5AM Venture Management, LLC 9.68M Mar 31, 2026 27.56% $1.65 0.00%
Versant Venture Management LLC 2.01M Mar 31, 2026 5.72% $0.87 0.00%
Baker Bros Advisors LP 1.58M Mar 31, 2026 4.48% $0.01 8.59%
Vanguard Group Inc 882.79K Dec 31, 2025 2.51% $0.00 0.00%
Vanguard Capital Management, LLC 764.46K Mar 31, 2026 2.18% $0.00 0.00%
Sphera Funds Management Ltd. 678.93K Mar 31, 2026 1.93% $0.07 41.76%
BlackRock Inc 286.13K Mar 31, 2026 0.81% $0.00 1.52%
Geode Capital Management, LLC 277.26K Mar 31, 2026 0.79% $0.00 31.93%
Millennium Management LLC 258.20K Mar 31, 2026 0.74% $0.00 -32.14%
Junked Platinum Investment Management Ltd 233.10K Mar 31, 2026 0.66% $0.04 0.00%
Vanguard Fiduciary Trust Co 104.23K Mar 31, 2026 0.30% $0.00 0.00%
State Street Corp 75.33K Mar 31, 2026 0.21% $0.00 0.00%
UBS Group AG 45.76K Mar 31, 2026 0.13% $0.00 244.44%
Two Sigma Advisers, LLC 40.98K Dec 31, 2025 0.12% $0.00 0.00%
XTX Topco Ltd 40.92K Mar 31, 2026 0.12% $0.00 -22.85%
Two Sigma Investments LLC 25.68K Mar 31, 2026 0.07% $0.00 -50.33%
Engineers Gate Manager LP 20.19K Mar 31, 2026 0.06% $0.00 -12.72%
Northern Trust Corp 20.14K Mar 31, 2026 0.06% $0.00 0.00%
Barclays PLC 18.09K Mar 31, 2026 0.05% $0.00 -14.88%
Group One Trading, LP 17.70K Dec 31, 2025 0.05% $0.00 634.32%

Shares Statistics

Shares Outstanding: 35.14M
Shares Float: 22.97M
% Insiders: 117.20%
% Institutions: 4,600.40%
Short % Float: 3.80%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 561.83K 1.60% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 184.98K 0.53% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 164.50K 0.47% ▼ 0.36% Apr 30, 2026
4 Abante Quant Value FI 72.70K 0.21% ▼ 27.05% Mar 31, 2026
5 iShares Micro-Cap ETF 49.87K 0.14% ▲ 0.00% May 29, 2026
6 Extended Equity Market Fund B 38.69K 0.11% ▲ 0.00% Dec 31, 2025
7 Blackrock Extended Mkt Fund CF 38.69K 0.11% ▲ 0.00% Apr 30, 2026
8 Extended Equity Market Fund E 38.69K 0.11% ▲ 0.00% Dec 31, 2025
9 BlackRock Extended Equity Market Fund K 32.95K 0.09% ▼ 0.73% Mar 31, 2026
10 Fidelity Total Market Index 30.64K 0.09% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $7.45M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $24.25M
EBITDA: $-58.36M
Book Value: $0.26
Earnings/Share: $-1.45
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -87.70%
ROE (TTM): -167.97%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.30x 0.01x 0.29x N/A 0.00x
2024-12-31 16.32x 0.00x 0.06x -31.20x -0.01x
2023-12-31 0.84x -2.08x 1.18x -38.33x -0.12x
2022-12-31 0.74x -0.64x 1.33x -27.59x -0.10x
2021-12-31 2.46x 0.35x 0.40x -10.22x -0.27x
2020-12-31 3.38x 3.32x 0.83x -8.90x -0.26x
2019-12-31 2.05x 0.71x 0.73x -6.63x 0.19x
2018-12-31 0.12x -0.09x 8.95x -49.52x -0.29x
2017-12-31 0.69x -0.29x 2.44x -5,785.61x -0.08x
2016-12-31 0.42x 0.00x 5.49x N/A 0.00x
2015-12-31 5.94x 0.00x 0.87x -8.27x 0.00x
2014-12-31 0.38x 0.00x 2.30x N/A 0.00x
2013-12-31 0.58x 0.00x 1.25x -3.37x 0.00x
2012-12-31 8.87x 0.00x 0.10x 6.45x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SKYE.US!